You may also like
Morbidity of Bleeding After Cardiac Surgery: Is it Blood Transfusion, Reoperation for Bleeding, or Both?
We sought to determine prevalence of and risk factors for reoperation for bleeding, separate the effect of reoperation from that of transfusion on hospital mortality and major morbidity, and identify the source of bleeding.
Terumo Americas Holding, Inc. Aquires Harvest Technologies
Terumo Americas Holding, Inc., a U.S. subsidiary of Japan’s Terumo Corporation, one of the world’s leading medical device manufacturers with $3.4 billion in sales and operations in more than 160 nations, today announced that it has entered into a Stock Purchase Agreement to acquire all outstanding shares of Harvest Technologies Corporation, an innovative biotechnology company working to commercialize the world’s first point-of-care technology that allows physicians to derive highly concentrated autologous, adult stem cells from their patients in just 15 minutes.
